We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Drugmaker Cited for Making Unapproved Drugs
Generic Drugmaker Cited for Making Unapproved Drugs
September 19, 2006
Icelandic generic drugmaker Actavis failed to conduct a follow-up investigation of a fatal adverse event, did not submit required reports on adverse drug experiences (ADEs) to the FDA and "manufactures numerous prescription drug products without approved applications," the agency said in a warning letter to the firm.